• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
JI Bo,ZHANG Yong,SHEN Yan.Participation of clinical pharmacist in analysis of one case of severe gastrointestinal adverse reactions caused by mycophenolate mofetil (MMF)of an nephrotic syndrome(NS)child[J].Journal Of Pharmaceutical Research,2018,37(2):119-121[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4242times   Download 3048次 QR Code for this article
Scan with your phone!
临床药师参与1例肾病综合征患儿初服吗替麦考酚酯导致严重胃肠道不良反应的病例分析
冀波1,张永2,沈雁3
Font:Larger+|Default|Smaller-
(1.郑州人民医院药学部,河南 郑州 450000;2.南京医科大学附属南京儿童医院药学部,江苏 南京 210000;3.中国药科大学药剂系,江苏 南京 210009)
摘要:
目的 探讨临床药师在参与吗替麦考酚酯(MMF)治疗肾病综合征(NS)患儿的治疗过程中的作用。方法 临床药师参与1例肾病综合征患儿在初服吗替麦考酚酯后出现严重胃肠道不适的治疗,为患儿治疗过程中提供合理的治疗建议,同时对患儿用药过程中进行药学监护。结果 患儿使用他克莫司控制尿蛋白欠佳,更换他克莫司为吗替麦考酚酯治疗肾病综合征,但在治疗过程中出现严重胃肠道不良反应,经分析可能与吗替麦考酚酯常见的胃肠道不良反应有关。结论 临床药师在临床治疗的过程中参与治疗方案的调整,对患儿进行用药指导,同时查阅文献发现对于吗替麦考酚酯胃肠道不良反应大部分患者可逐渐耐受,因此建议患儿胃肠道症状好转后继续服用吗替麦考酚酯。
关键词:  霉酚酸酯  肾病综合征  不良反应  临床药师
DOI:10.13506/j.cnki.jpr.2018.02.015
基金项目:国家自然科学基金(No.81501579)
Participation of clinical pharmacist in analysis of one case of severe gastrointestinal adverse reactions caused by mycophenolate mofetil (MMF)of an nephrotic syndrome(NS)child
JI Bo1,ZHANG Yong2,SHEN Yan3
(1.Department of Pharmacy,Zhengzhou People's Hospital,Zhengzhou 450000,China;2.Department of Pharmacy,Nanning Children,s Hospital,Nanjing Medical University,Nanjing 210000,China;3.Department of Pharmaceutics,China Pharmaceutical University,Nanjing 210009,China)
Abstract:
Objective To explore the role of clinical pharmacists in the treatment of children with nephrotic syndrome (NS) in MMF administration.Methods The clinical pharmacists participated in 1 case therapy of children with NS in the early treatment of MMF administration with severe gastrointestinal discomfort to provide reasonable suggestions.Meanwhile,pharmaceutical monitoring was provided for the children in the process of the drug administration.Results Since urinary protein control was poor after taking tacrolimus,tacrolimu was successfully replaced by MMF for nephrotic syndrome (NS) in this treatment and eventually result in severe gastrointestinal adverse reactions,which may be related to the gastrointestinal adverse reactions common in MMF.Conclusion Clinical pharmacists participated in the adjustment of treatment program and provided medication guidances and individualized monitoring during the clinical treatment,it was indicated that the majority of patients can gradually tolerant the MMF gastrointestinal adverse reaction according to some references,therefore it was recommended to continue taking MMF after the gastrointestinal symptoms was improved.Meanwhile,the pharmaceutical care for the children in the process of administration indicated their professional value.
Key words:  Mycophenolate mofetil  Nephrotic syndrome  Adverse reaction  Clinical pharmacist
Today's Visits:445    Total Visits:2383128
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.